Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder

NACompletedINTERVENTIONAL
Enrollment

436

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

April 30, 2008

Study Completion Date

February 28, 2009

Conditions
Patent Ductus Arteriosus (PDA)
Interventions
DEVICE

Device closure with AMPLATZER Duct Occluder

Device closure with AMPLATZER Duct Occluder

OTHER

Objective Performance Criteria

Compare results of device closure to objective performance criteria

Trial Locations (24)

10032

Columbia University, New York

14642

Childrens Hospital, Rochester

20010

Children's National Medical Center, Washington D.C.

27599

University of North Carolina, Chapel Hill

29425

Medical University of South Carolina, Charleston

30322

Children's Hospital of the King's Daughters, Norfolk

32610

University of Florida, Gainesville

32806

Arnold Palmer Hospital, Orlando

35294

University of Alabama, Birmingham

39216

University of Mississippi Medical Center, Jackson

46202

Indiana University School of Medicine, Indianapolis

53201

Children's Hospital of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic, Rochester

60637

University of Chicago, Chicago

63110

Washington University Medical Center, St Louis

68114

Children's Hospital UN/CU), Omaha

70112

Louisana State University Medical Center, New Orleans

75235

University of Texas, Dallas

76104

Cook Children's Heart Center, Fort Worth

80218

Children's Hospital, Denver

92123

Children's Hospital, San Diego

98195

University of Washington Medical Center, Seattle

02111

New England Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY